A Novel Tendon Injury Model, Induced by Collagenase Administration Combined with a Thermo-Responsive Hydrogel in Rats, Reproduces the Pathogenesis of Human Degenerative Tendinopathy.

Pluronic animal model collagenases hydrogels injections patellar ligament rats tendinopathy ultrasonography

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
03 Feb 2024
Historique:
received: 22 12 2023
revised: 25 01 2024
accepted: 29 01 2024
medline: 10 2 2024
pubmed: 10 2 2024
entrez: 10 2 2024
Statut: epublish

Résumé

Patellar tendinopathy is a common clinical problem, but its underlying pathophysiology remains poorly understood, primarily due to the absence of a representative experimental model. The most widely used method to generate such a model is collagenase injection, although this method possesses limitations. We developed an optimized rat model of patellar tendinopathy via the ultrasound-guided injection of collagenase mixed with a thermo-responsive Pluronic hydrogel into the patellar tendon of sixty male Wistar rats. All analyses were carried out at 3, 7, 14, 30, and 60 days post-injury. We confirmed that our rat model reproduced the pathophysiology observed in human patients through analyses of ultrasonography, histology, immunofluorescence, and biomechanical parameters. Tendons that were injured by the injection of the collagenase-Pluronic mixture exhibited a significant increase in the cross-sectional area (

Identifiants

pubmed: 38339145
pii: ijms25031868
doi: 10.3390/ijms25031868
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Laura Vidal (L)

Leitat Technological Center, Carrer de la Innovació 2, 08225 Terrassa, Spain.
Bioengineering, Cell Therapy and Surgery in Congenital Malformations Laboratory, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain.

Maria Lopez-Garzon (M)

Leitat Technological Center, Carrer de la Innovació 2, 08225 Terrassa, Spain.
Bioengineering, Cell Therapy and Surgery in Congenital Malformations Laboratory, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain.

Vanesa Venegas (V)

Leitat Technological Center, Carrer de la Innovació 2, 08225 Terrassa, Spain.
Bioengineering, Cell Therapy and Surgery in Congenital Malformations Laboratory, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain.

Ingrid Vila (I)

Leitat Technological Center, Carrer de la Innovació 2, 08225 Terrassa, Spain.
Bioengineering, Cell Therapy and Surgery in Congenital Malformations Laboratory, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain.

David Domínguez (D)

Medical Department of Futbol Club Barcelona (FIFA Medical Center of Excellence) and Barça Innovation, 08970 Sant Joan Despí, Spain.

Gil Rodas (G)

Leitat Technological Center, Carrer de la Innovació 2, 08225 Terrassa, Spain.
Medical Department of Futbol Club Barcelona (FIFA Medical Center of Excellence) and Barça Innovation, 08970 Sant Joan Despí, Spain.
Sports Medicine Unit, Hospital Clínic and Sant Joan de Déu, 08950 Barcelona, Spain.
Faculty of Medicine and Health Sciences, University of Barcelona, 08007 Barcelona, Spain.

Mario Marotta (M)

Leitat Technological Center, Carrer de la Innovació 2, 08225 Terrassa, Spain.
Bioengineering, Cell Therapy and Surgery in Congenital Malformations Laboratory, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain.

Classifications MeSH